T. Rowe Price Associates’s BlueLinx BXC Stock Holding History
Bought
Maintained
Sold
Other funds holding BXC
GJL
JCP
VCM
PAIM
RRAM
T. Rowe Price Associates's BXC Position: Q1 2026 in Review
T. Rowe Price Associates increased its BlueLinx (BXC) stake by 13% in Q1 2026, buying an estimated $127K and bringing the position to 16,281 shares worth $883K. The position accounts for ﹤0.01% of the portfolio, ranked #2216.
T. Rowe Price Associates first reported a position in BXC in Q2 2013 and has held it in 29 quarters since. The position peaked at $2.72M in Q4 2024. 145 funds tracked by Wall St. Rank hold BXC as of Q1 2026.
- T. Rowe Price Associates held 16,281 shares of BlueLinx worth $883K as of Q1 2026.
- T. Rowe Price Associates bought 1,928 BlueLinx shares in Q1 2026, an estimated $127K.
- BlueLinx made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #2216 holding.
- T. Rowe Price Associates first reported a position in BlueLinx in Q2 2013 and has held it in 29 quarters since.
- T. Rowe Price Associates's BlueLinx position peaked at $2.72M in Q4 2024.
- 145 funds tracked by Wall St. Rank held BlueLinx as of Q1 2026.
Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.